MedTrace Logo

First-In-Human Intracoronary OCT-FLIm In Patients Undergoing PCI

NCT04835467 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-12-04

No results posted yet for this study

Summary

Patients will undergo intracoronary imaging using combined optical coherence tomography-fluorescence lifetime imaging (OCT-FLIm) during percutaneous coronary intervention, and the obtained imaging data will be used to assess the efficacy of this dual-modal catheter imaging strategy in characterizing high-risk plaque.

Conditions

  • Atherosclerosis Coronary Artery With Angina Pectoris
  • Atheroscleroses, Coronary
  • Atherosclerotic Plaque
  • Thin-cap fIbroatheroma
  • Atherosclerosis

Interventions

DEVICE

Dual-modal OCT-FLIm

Intracoronary imaging using dual-modal OCT-FLIm catheter

Sponsors & Collaborators

  • Korea University Guro Hospital

    lead OTHER

Principal Investigators

  • Sunwon Kim, MD, PhD · Korea University Ansan Hospital

  • Dong Oh Kang, MD, PhD · Korea University Guro Hospital

  • Jin Won Kim, MD, PhD · Korea University Guro Hospital

  • Hongki Yoo, PhD · Korea Advanced Institute of Science and Technology

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-14
Primary Completion
2022-08-18
Completion
2023-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04835467 on ClinicalTrials.gov